multiple sclerosis
-
anti-CD20 therapy, Brain, cladribine, Delphi consensus, disease modifying therapy, high efficacy DMTs, multiple sclerosis, Neurodegenerative Diseases, neurology, neuroscience, patient involvement, personalized therapy, treatment adherenceMultiple Sclerosis Personalized Therapy: 70% Delphi Consensus
An Italian multiple sclerosis Delphi panel reached consensus on 116 of 166…
-
basal ganglia, Brain, cognition, cognitive impairment, deep gray matter, iron MRI, multiple sclerosis, Neurodegenerative Diseases, neuroimaging biomarkers, neuroscience, paramagnetic rim lesions, quantitative susceptibility mapping, SDMT, thalamusMultiple Sclerosis Iron MRI Linked to Cognitive Impairment in 12 Studies
A 2026 systematic review of advanced neuroimaging in multiple sclerosis narrowed 600…
-
Brain, exercise, fall risk, fatigue, frailty, multiple sclerosis, Neurodegenerative Diseases, pilot randomized trial, Psychiatry, Psychology, quality of life, rehabilitation, resistance training, therapy, treadmill training, Virtual realityMultiple Sclerosis Frailty Exercise Improved Fatigue in 6 Weeks
A 2026 pilot randomized trial in 16 frail adults with multiple sclerosis…
-
blood biomarkers, Brain, demyelination, disease activity, medRxiv preprint, multiple sclerosis, myelin oligodendrocyte glycoprotein, Neurodegenerative Diseases, neurofilament light chain, neuroscience, relapse, remission, serum MOGSerum MOG Blood Biomarker Rose During Multiple Sclerosis Relapse
A 2026 medRxiv case-control study found that serum myelin oligodendrocyte glycoprotein was…
-
autoimmune psychiatry, Brain, CSF biomarkers, immunopsychiatry, multiple sclerosis, neuroinflammation, neuroscience, OCD, Psychiatry, psychosis, sCD27, soluble CD27, T-cell activationsCD27 Biomarker Flags Autoimmune Disease in Severe Psychiatric Disorders
A 2026 immunopsychiatry cohort study found that soluble CD27 (sCD27), a marker…
